Maravai LifeSciences Holdings, Inc.
NASDAQ: MRVI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Bernd Brust
- Employees
- 570
- Headquarters
- San Diego, United States
- IPO year
- 2020
- Market cap
- $1.6B
- Website
- https://www.maravai.com
Loading MRVI…
Loading profile data…Frequently asked questions about MRVI
What does Maravai LifeSciences Holdings, Inc. (MRVI) do?
Maravai LifeSciences Holdings, Inc. is a life sciences company operating globally, supplying essential products that facilitate the advancement of drug therapies, diagnostics, innovative vaccines, and research into human diseases. Its diverse product line supports critical stages of biopharmaceutical development, featuring nucleic acids for both...
Where does MRVI trade?
Maravai LifeSciences Holdings, Inc. (MRVI) trades on the NASDAQ Global Select.
What sector is MRVI in?
Maravai LifeSciences Holdings, Inc. (MRVI) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Maravai LifeSciences Holdings, Inc.?
Bernd Brust is the chief executive officer of Maravai LifeSciences Holdings, Inc. (MRVI).
Where is Maravai LifeSciences Holdings, Inc. headquartered?
Maravai LifeSciences Holdings, Inc. is headquartered in United States.
Does MRVI pay a dividend?
Maravai LifeSciences Holdings, Inc. (MRVI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MRVI go public?
Maravai LifeSciences Holdings, Inc. (MRVI) completed its initial public offering in 2020.